Sheaff Brock Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,000	Closed	-$327K	–	480
2019 Q2	$327K	Buy	+3,000	New	+$319K	0.04%	321

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sheaff Brock Investment Advisors's IBB Position: Q1 2022 in Review

Sheaff Brock Investment Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 1,430 shares — an estimated $218K sold.

Sheaff Brock Investment Advisors first reported a position in IBB in Q4 2015 and held it in 24 quarters. The position peaked at $570K in Q1 2017. 898 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Sheaff Brock Investment Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
Sheaff Brock Investment Advisors sold 1,430 iShares Biotechnology ETF shares in Q1 2022, an estimated $218K.
Sheaff Brock Investment Advisors first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 24 quarters.
Sheaff Brock Investment Advisors's iShares Biotechnology ETF position peaked at $570K in Q1 2017.
898 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2022, filed 6 May 2022.